G Medical Innovations Holdings Ltd
GMVD · NASDAQ
12/31/2022 | 6/30/2022 | 12/31/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Revenue | – | – | -$0 | $0 |
| % Growth | – | – | -102.5% | – |
| Cost of Goods Sold | – | – | $0 | $0 |
| Gross Profit | – | – | -$0 | $0 |
| % Margin | – | – | 1,111.1% | 56.5% |
| R&D Expenses | – | – | $0 | $0 |
| G&A Expenses | – | – | $0 | $0 |
| SG&A Expenses | – | – | $0 | $0 |
| Sales & Mktg Exp. | – | – | -$0 | $0 |
| Other Operating Expenses | – | – | $0 | -$0 |
| Operating Expenses | – | – | $0 | -$0 |
| Operating Income | – | – | $0 | -$0 |
| % Margin | – | – | -1,607.6% | -233.3% |
| Other Income/Exp. Net | – | – | $0 | -$0 |
| Pre-Tax Income | – | – | $0 | -$0 |
| Tax Expense | – | – | $0 | -$0 |
| Net Income | – | – | $0 | -$0 |
| % Margin | – | – | -13,308.7% | -616.4% |
| EPS | – | – | 1.61 | -47.5 |
| % Growth | – | – | 103.4% | – |
| EPS Diluted | – | – | 1.61 | -47.5 |
| Weighted Avg Shares Out | – | – | 0 | 0 |
| Weighted Avg Shares Out Dil | – | – | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | – | $0 | $0 |
| Interest Expense | – | – | -$0 | $0 |
| Depreciation & Amortization | – | – | -$0 | $0 |
| EBITDA | – | – | $0 | -$0 |
| % Margin | – | – | -9,628.3% | -412.5% |